Cargando…

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression

OBJECTIVES: To use a data-driven approach to determine the existence and natural history of subtypes of Parkinson’s disease (PD) using two large independent cohorts of patients newly diagnosed with this condition. METHODS: 1601 and 944 patients with idiopathic PD, from Tracking Parkinson’s and Disco...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawton, Michael, Ben-Shlomo, Yoav, May, Margaret T, Baig, Fahd, Barber, Thomas R, Klein, Johannes C, Swallow, Diane M A, Malek, Naveed, Grosset, Katherine A, Bajaj, Nin, Barker, Roger A, Williams, Nigel, Burn, David J, Foltynie, Thomas, Morris, Huw R, Wood, Nicholas W, Grosset, Donald G, Hu, Michele T M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288789/
https://www.ncbi.nlm.nih.gov/pubmed/30464029
http://dx.doi.org/10.1136/jnnp-2018-318337
_version_ 1783379859924320256
author Lawton, Michael
Ben-Shlomo, Yoav
May, Margaret T
Baig, Fahd
Barber, Thomas R
Klein, Johannes C
Swallow, Diane M A
Malek, Naveed
Grosset, Katherine A
Bajaj, Nin
Barker, Roger A
Williams, Nigel
Burn, David J
Foltynie, Thomas
Morris, Huw R
Wood, Nicholas W
Grosset, Donald G
Hu, Michele T M
author_facet Lawton, Michael
Ben-Shlomo, Yoav
May, Margaret T
Baig, Fahd
Barber, Thomas R
Klein, Johannes C
Swallow, Diane M A
Malek, Naveed
Grosset, Katherine A
Bajaj, Nin
Barker, Roger A
Williams, Nigel
Burn, David J
Foltynie, Thomas
Morris, Huw R
Wood, Nicholas W
Grosset, Donald G
Hu, Michele T M
author_sort Lawton, Michael
collection PubMed
description OBJECTIVES: To use a data-driven approach to determine the existence and natural history of subtypes of Parkinson’s disease (PD) using two large independent cohorts of patients newly diagnosed with this condition. METHODS: 1601 and 944 patients with idiopathic PD, from Tracking Parkinson’s and Discovery cohorts, respectively, were evaluated in motor, cognitive and non-motor domains at the baseline assessment. Patients were recently diagnosed at entry (within 3.5 years of diagnosis) and were followed up every 18 months. We used a factor analysis followed by a k-means cluster analysis, while prognosis was measured using random slope and intercept models. RESULTS: We identified four clusters: (1) fast motor progression with symmetrical motor disease, poor olfaction, cognition and postural hypotension; (2) mild motor and non-motor disease with intermediate motor progression; (3) severe motor disease, poor psychological well-being and poor sleep with an intermediate motor progression; (4) slow motor progression with tremor-dominant, unilateral disease. Clusters were moderately to substantially stable across the two cohorts (kappa 0.58). Cluster 1 had the fastest motor progression in Tracking Parkinson’s at 3.2 (95% CI 2.8 to 3.6) UPDRS III points per year while cluster 4 had the slowest at 0.6 (0.1–1.1). In Tracking Parkinson’s, cluster 2 had the largest response to levodopa 36.3% and cluster 4 the lowest 28.8%. CONCLUSIONS: We have found four novel clusters that replicated well across two independent early PD cohorts and were associated with levodopa response and motor progression rates. This has potential implications for better understanding disease pathophysiology and the relevance of patient stratification in future clinical trials.
format Online
Article
Text
id pubmed-6288789
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-62887892018-12-27 Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression Lawton, Michael Ben-Shlomo, Yoav May, Margaret T Baig, Fahd Barber, Thomas R Klein, Johannes C Swallow, Diane M A Malek, Naveed Grosset, Katherine A Bajaj, Nin Barker, Roger A Williams, Nigel Burn, David J Foltynie, Thomas Morris, Huw R Wood, Nicholas W Grosset, Donald G Hu, Michele T M J Neurol Neurosurg Psychiatry Movement Disorders OBJECTIVES: To use a data-driven approach to determine the existence and natural history of subtypes of Parkinson’s disease (PD) using two large independent cohorts of patients newly diagnosed with this condition. METHODS: 1601 and 944 patients with idiopathic PD, from Tracking Parkinson’s and Discovery cohorts, respectively, were evaluated in motor, cognitive and non-motor domains at the baseline assessment. Patients were recently diagnosed at entry (within 3.5 years of diagnosis) and were followed up every 18 months. We used a factor analysis followed by a k-means cluster analysis, while prognosis was measured using random slope and intercept models. RESULTS: We identified four clusters: (1) fast motor progression with symmetrical motor disease, poor olfaction, cognition and postural hypotension; (2) mild motor and non-motor disease with intermediate motor progression; (3) severe motor disease, poor psychological well-being and poor sleep with an intermediate motor progression; (4) slow motor progression with tremor-dominant, unilateral disease. Clusters were moderately to substantially stable across the two cohorts (kappa 0.58). Cluster 1 had the fastest motor progression in Tracking Parkinson’s at 3.2 (95% CI 2.8 to 3.6) UPDRS III points per year while cluster 4 had the slowest at 0.6 (0.1–1.1). In Tracking Parkinson’s, cluster 2 had the largest response to levodopa 36.3% and cluster 4 the lowest 28.8%. CONCLUSIONS: We have found four novel clusters that replicated well across two independent early PD cohorts and were associated with levodopa response and motor progression rates. This has potential implications for better understanding disease pathophysiology and the relevance of patient stratification in future clinical trials. BMJ Publishing Group 2018-12 2018-07-25 /pmc/articles/PMC6288789/ /pubmed/30464029 http://dx.doi.org/10.1136/jnnp-2018-318337 Text en © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY. Published by BMJ. This is an Open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Movement Disorders
Lawton, Michael
Ben-Shlomo, Yoav
May, Margaret T
Baig, Fahd
Barber, Thomas R
Klein, Johannes C
Swallow, Diane M A
Malek, Naveed
Grosset, Katherine A
Bajaj, Nin
Barker, Roger A
Williams, Nigel
Burn, David J
Foltynie, Thomas
Morris, Huw R
Wood, Nicholas W
Grosset, Donald G
Hu, Michele T M
Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
title Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
title_full Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
title_fullStr Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
title_full_unstemmed Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
title_short Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
title_sort developing and validating parkinson’s disease subtypes and their motor and cognitive progression
topic Movement Disorders
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288789/
https://www.ncbi.nlm.nih.gov/pubmed/30464029
http://dx.doi.org/10.1136/jnnp-2018-318337
work_keys_str_mv AT lawtonmichael developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT benshlomoyoav developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT maymargarett developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT baigfahd developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT barberthomasr developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT kleinjohannesc developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT swallowdianema developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT maleknaveed developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT grossetkatherinea developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT bajajnin developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT barkerrogera developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT williamsnigel developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT burndavidj developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT foltyniethomas developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT morrishuwr developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT woodnicholasw developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT grossetdonaldg developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression
AT humicheletm developingandvalidatingparkinsonsdiseasesubtypesandtheirmotorandcognitiveprogression